NON SMALL CELL LUNG CANCER NSCLC
Clinical trials for NON SMALL CELL LUNG CANCER NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost lung cancer control without surgery
Disease control Not yet recruitingThis study tests whether adding Huaier granules to microwave ablation (a heat-based tumor treatment) helps control stage IA non-small cell lung cancer better than ablation alone. About 180 adults who cannot have surgery will be randomly assigned to one of the two groups. The main…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE3 • Sponsor: Xin Ye • Aim: Disease control
Last updated May 16, 2026 23:49 UTC
-
New hope for advanced lung cancer: experimental drug JSKN033 enters phase II trial
Disease control Not yet recruitingThis study tests a new drug called JSKN033 in 160 people with advanced non-small cell lung cancer that cannot be cured. The goal is to see if the drug is safe and shrinks tumors. The trial has two parts: first finding the best dose, then testing it in more patients.
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New hope for Hard-to-Treat cancers: drug targets RAS mutations
Disease control Not yet recruitingThis study tests a new drug called BPI-572270 in 120 adults with advanced solid tumors (lung, colon, or pancreatic cancer) that have specific RAS gene mutations. The goal is to see if the drug is safe and can shrink or control the tumors. Participants must have already tried stan…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 16, 2026 23:43 UTC
-
New drug combo targets brain metastases in lung cancer patients
Disease control Not yet recruitingThis study looks at two different doses of the drug furmonertinib, either alone or with chemotherapy, as a first treatment for people with a specific type of lung cancer (EGFR-mutated NSCLC) that has spread to the brain. The goal is to see which approach works better and is safer…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo aims to fight lung cancer that outsmarted earlier drugs
Disease control Not yet recruitingThis study tests a combination of limertinib (a targeted pill) plus two chemotherapy drugs (carboplatin and etoposide) in 30 adults with a specific type of lung cancer. These patients had non-small cell lung cancer with an EGFR mutation, but after initial targeted therapy stopped…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
New drug combo targets advanced cancers in early trial
Disease control Not yet recruitingThis study tests a new drug called QLS5132, given with other cancer treatments, for people with advanced solid tumors like stomach, lung, ovarian, or endometrial cancer. The goal is to find safe doses and see if the combination shrinks tumors. About 626 participants will receive …
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Lung cancer patients to test athletic recovery program
Symptom relief Not yet recruitingThis pilot study will enroll 10 people who had surgery for early-stage non-small cell lung cancer. Participants will follow a 6-month athletic program supervised by a sports scientist. The goal is to see if exercise can improve lung function, fitness, and quality of life after su…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Real-World data to reveal if immunotherapy combo shrinks lung tumors before surgery
Knowledge-focused Not yet recruitingThis study will review medical records of 100 adults in Taiwan with early-stage non-small cell lung cancer who received nivolumab (an immunotherapy) plus chemotherapy before surgery. Researchers want to see how many patients have no cancer left after treatment and how long they s…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 16, 2026 23:46 UTC
-
Simple blood test could predict immunotherapy success in multiple cancers
Knowledge-focused Not yet recruitingThis study aims to develop a blood test that can predict whether a patient with certain cancers (like lung, skin, or breast cancer) will benefit from immunotherapy. Researchers will analyze a specific type of white blood cell (neutrophils) from blood samples taken before treatmen…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Can ancient chinese medicine predict lung cancer drug success?
Knowledge-focused Not yet recruitingThis study looks at how Traditional Chinese Medicine (TCM) body patterns, like tongue and pulse readings, relate to how well targeted lung cancer drugs (EGFR-TKIs) work. About 3000 people with a specific type of lung cancer will be followed for up to 5 years. Researchers will col…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
Smart wearables aim to boost lung cancer surgery recovery
Knowledge-focused Not yet recruitingThis study tests a new system that uses wearable devices and a smartphone app to help people with non-small cell lung cancer recover after chest surgery. About 126 participants will either get standard care or use the wearable system, which tracks their activity and guides home e…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: NA • Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC